Article
Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene.
Pharmacogenetics and genomics - 1 Nov 2010
Appell Malin Lindqvist, Wennerstrand Patricia, Peterson Curt, Hertervig Erik, Mårtensson Lars-Göran
Abstract excerpt
BACKGROUND: The activity of the human enzyme thiopurine methyltransferase (TPMT) varies greatly between individuals because of genetic polymorphism. TPMT is involved in the detoxification and activation of thiopurines such as 6-mercaptopurine, 6-thioguanine, and azathioprine. These drugs are used in the treatment of acute lymphoblastic leukemia and inflammatory bowel disease. A total of 29 sequence variants have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
